ANKMJ
Ankyra Medical Journal

Ankyra Medical Journal (AnkMJ), formerly known as the Journal of Translational and Practical Medicine, regularly publishes international quality issues in the field of Medicine in the light of current information.

eISSN: 3023-655X
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Review
Pneumonies
Abstract
Pneumonia is an inflammation of the alveolar space distal to the terminal bronchiole in the lung parenchyma. The inflammation seen in pneumonia is mostly caused by microorganisms such as viruses, bacteria, and fungi, but can also be caused by non-infectious causes (toxic substance inhalation, radiation damage, hypersensitivity reaction-pneumonitis, autoimmunity). Pneumonia can be observed in three forms: community-acquired pneumonia (CAP), hospital-acquired pneumonia (HAP), and ventilator-associated pneumonia (VAP). Patients with pneumonia usually present with cough, fever, sputum, chest pain, dyspnea, and hemoptysis. In addition, patients may have nonspecific symptoms. CAPs are caused by typical (S. pneumoniae) and atypical (C. pneumoniae, M. pneumoniae, and L. pneumoniae) agents. On presentation, fever, pulse rate, respiratory rate, oxygen saturation, blood pressure, and auscultation should be performed. Typical chest radiographic findings in the diagnosis of CAP include lobar consolidations, interstitial infiltrates, and/or cavitations. Acute-phase reactants may be elevated in response to infection and inflammation in pneumonia. The first decision to be made in cases of pneumonia is the determination of the need for hospitalization and the choice of antibiotherapy. If possible, cultures should be taken before antibiotics are started on the patient for whom hospitalization is planned. After 72 hours, in patients with no symptom improvement, the reason for treatment non-response should be evaluated, and antibiotherapy should be changed if necessary.

Keywords : Antibiotherapy, community-acquired pneumonia, hospital-acquired pneumonia

Download Article


1. Tabah A, Buetti N, Staiquly Q, et al. Epidemiology and outcomesof hospital-acquired bloodstream infections in intensive care unitpatients: the EUROBACT-2 international cohort study. IntensiveCare Med. 2023;49(2):178-190.
2. Cillóniz C, Torres A, Niederman MS. Management of pneumoniain critically ill patients. BMJ. 2021;375.
3. Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatmentof adults with community-acquired pneumonia. An officialclinical practice guideline of the American Thoracic Society andInfectious Diseases Society of America. Am J Respirat Critic CareMed. 2019;200(7):e45-e67.
4. Grabill N, Louis M, Idowu C, et al. Lung cavitation topneumothorax: a case report of the multilayered respiratorychallenges in oncology patients. Internat J Surg Case Rep.2023;109157.
5. Gökırmak M, Hasanoğlu HC, Yıldırım Z, et al. Türk ToraksDerneği Pnömoni Rehberi’ne uygun tedavi verilen ve verilmeyentoplum kökenli pnömonilerde başarı oranları. 2001.
6. Musher DM, Roig IL, Cazares G, et al. Can an etiologic agentbe identified in adults who are hospitalized for community-acquired pneumonia: results of a one-year study. J Infect.2013;67(1):11-18.
7. Klompas M, Imrey PB, Yu PC, et al. Respiratory viral testingand antibacterial treatment in patients hospitalized withcommunity-acquired pneumonia. Infect Contr Hosp Epidemiol.2021:42(7):817-825.
8. Tapan ÖO, Tapan U. Tedavi rehberlerine uygun olarakhastaneye yatırılan ve tedavi edilen toplumda gelişenpnömonili yaşlı bireylerin klinik seyir ve tedavi başarısınındeğerlendirilmesi.İzmir Göğüs Hasta Derg. 2020;34(1):12-19.
9. Van der Lee L, Patman S, Hill AM. Development of a clinicalpractice guideline for physiotherapy management of adultsinvasively ventilated with community-acquired pneumonia.Physiother. 2023.
10. File Jr, T. M, Bartlett JG, Thorner AR. Treatment of community-acquired pneumonia in adults in the outpatient setting. 2015.
11. Jokinen C, Heiskanen L, Juvonen H, et al. Incidence ofcommunity-acquired pneumonia in the population offour municipalities in eastern Finland. Am J Epidemiol.1993;137(9):977-988.
12. Guliyev U. D. E. K, Başyiğit İ. Solunum sistemi hastalıklarındasemptomlar. Akciğer Hastalık Anamnez. 2023;39.
13. LA, Ismael PF, Alexandre TM, et al. Community-acquiredpneumonia: epidemiology, diagnosis, prognostic severity scales,and new therapeutic options. Medwave. 2023;23(11):e2719-e2719.doi: 10.5867/medwave.2023.11.2719
14. Kilbert B, Kehr A, David Lim SY, et al. Effect of OMT on hospitallength of stay in elderly patients with pneumonia: a meta-analysis. Scholar: Pilot Validat Stud. 2022;3(1):5-9.
15. Vivek Jayaschandran MD. Severity assessment of pneumonia.World Clin Pulmon Critic Care Med: Pneumonia. 2019;6.
16. Chongthanadon B, Thirawattanasoot N, Ruangsomboon O.Clinical factors associated with in-hospital mortality in elderlyversus non-elderly pneumonia patients in the emergencydepartment. BMC Pulmon Med. 2023;23(1):330.
17. Öğe N. Necmettin Erbakan Üniversitesi Meram Tıp Fakültesigöğüshastalıkları yoğun bakım ünitesinde entübe halde takipedilenpnömonili hastalarda bronkoalveolar lavaj ve trakealaspiratmateryallerinin kültürlerinin ve gram boyamalarınınkıyaslanması. 2023.
18. Şen P, Demirdal T, Nemli SA. Pnömokok İnfeksiyonlarınınklinik özellikleri ve invazif hastalık göstergeleri. Klimik Derg.2022;35(3).
19. Torumkuney D, Tunger A, Sancak B, et al. Results from thesurvey of antibiotic resistance (SOAR) 2015-2017 in Turkey: databased on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints. J AntimicrobiChemotherap. 2020;75(1):88-99.
20. Al-Jardani A, Al Rashdi A, Al Jaaidi A, et al. Serotype distributionand antibiotic resistance among invasive Streptococcuspneumoniae from Oman post 13-valent vaccine introduction.Internat J Infect Dis. 2019;85:135-140.
21. Tapan ÖO, Tapan U. Tedavi rehberlerine uygun olarak hastaneyeyatırılan ve tedavi edilen toplumda gelişen pnömonili yaşlıbireylerin klinik seyir ve tedavi başarısının değerlendirilmesi.İzmir Göğüs Hasta Derg. 2020;34(1):12-19.
22. Balasar B, Ergün MÇ, Ergün B, Eroğlu E. Assessment ofhealthcare associated infections in a medical intensive care unit.Dicle Tıp Derg. 2023;311-318.
23. Shi Y, Huang Y, Zhang TT, et al. Chinese guidelines for thediagnosis and treatment of hospital-acquired pneumonia andventilator-associated pneumonia in adults (2018 Edition). JThoracic Dis. 2019;11(6):2581.
24. Dollard P, Griffin I, Berro A, et al. Risk assessment andmanagement of COVID-19 among travelers arriving at designatedUS airports, January 17-September 13, 2020. Morbidity MortalityWeekly Rep. 2020;69(45):1681.
25. Wilson KC, Schoenberg NC, Cohn DL, et al. Community-acquired pneumonia guideline recommendations-impact of aconsensus-based process versus systematic reviews. Clinic InfectDis. 2021;73(7):1467-1475.
Article available in :
Volume 2, Issue 3, 2023
Page : 126-134
https://doi.org/10.51271/JTPM-0054
Article Information
Received : 28 Nov 2023
Accepted : 29 Dec 2023
Published : 31 Dec 2023
Corresponding Author :

Esma Sevil Akkurt: Department of Chest Diseases, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkiye

[email protected]
Citation : Akkurt ES, Bayraktar M. Pneumonies. J Transl Pract Med. 2023;2(3):126-134.

Read: 549
Download : 785
Cited: 0
_Footer